Alison Bauerlein net worth and biography

Alison Bauerlein Biography and Net Worth

CFO of Inogen

Alison Bauerlein biography

Alison Bauerlein is Executive Vice President - Finance and Chief Financial Officer, Corporate Secretary and Corporate Treasurer of Inogen, Inc. Ms. Bauerlein is a co-founder of Inogen and has served as our Chief Financial Officer since 2009 and Executive Vice President, Finance since March 2014. Ms. Bauerlein has also served as Corporate Secretary and Corporate Treasurer since 2002. Ms. Bauerlein previously served as our Vice President, Finance from 2008 until March 2014. Prior to serving in these positions, Ms. Bauerlein also served as Controller with our company from 2008 to 2009 and 2001 to 2004, and the Director of Financial Planning and Analysis from 2004 to 2008. Ms. Bauerlein has over 18 years of experience in treasury, finance, accounting, risk management as well as strategic and tactical cost analysis and forecasting. Ms. Bauerlein received a Bachelor of Arts degree in Economics/Mathematics with high honors from the University of California, Santa Barbara.

What is Alison Bauerlein's net worth?: The estimated net worth of Alison Bauerlein is at least $3.95 million as of October 1st, 2024. Ms. Bauerlein owns 392,555 shares of Inogen stock worth more than $3,945,178 as of November 16th. This net worth evaluation does not reflect any other investments that Ms. Bauerlein may own. Learn More about Alison Bauerlein's net worth.
How do I contact Alison Bauerlein?: The corporate mailing address for Ms. Bauerlein and other Inogen executives is 326 BOLLAY DRIVE, GOLETA CA, 93117. Inogen can also be reached via phone at (805) 562-0500 and via email at [email protected]. Learn More on Alison Bauerlein's contact information.
Has Alison Bauerlein been buying or selling shares of Inogen?: Alison Bauerlein has not been actively trading shares of Inogen in the last ninety days. Most recently, Alison Bauerlein sold 1,397 shares of the business's stock in a transaction on Monday, August 2nd. The shares were sold at an average price of $80.33, for a transaction totalling $112,221.01. Following the completion of the sale, the chief financial officer now directly owns 12,014 shares of the company's stock, valued at $965,084.62. Learn More on Alison Bauerlein's trading history.
Who are Inogen's active insiders?: Inogen's insider roster includes Alison Bauerlein (CFO), Raymond Huggenberger (Director), Byron Myers (EVP), and Brenton Taylor (EVP). Learn More on Inogen's active insiders.
Are insiders buying or selling shares of Inogen?: In the last year, insiders at the medical technology company sold shares 1 times. They sold a total of 10,000 shares worth more than $85,600.00. The most recent insider tranaction occured on May, 10th when EVP Jason Somer sold 10,000 shares worth more than $85,600.00. Insiders at Inogen own 1.0% of the company. Learn More about insider trades at Inogen.
Information on this page was last updated on 5/10/2024.

Alison Bauerlein Insider Trading History at Inogen

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/2/2021	Sell	1,397	$80.33	$112,221.01	12,014
7/30/2021	Sell	8,235	$80.01	$658,882.35
7/27/2021	Sell	9,632	$75.02	$722,592.64	13,411
4/13/2021	Sell	1,200	$60.00	$72,000.00	4,524
3/15/2021	Sell	18,098	$52.23	$945,258.54	21,422
2/16/2021	Sell	18,098	$53.88	$975,120.24	20,413
1/26/2021	Sell	8,973	$50.04	$449,008.92	11,288
1/15/2021	Sell	18,098	$44.34	$802,465.32	20,413
12/15/2020	Sell	8,702	$40.16	$349,472.32	11,017
6/11/2018	Sell	5,000	$180.69	$903,450.00	9,161
3/8/2018	Sell	15,911	$124.48	$1,980,601.28	20,072
2/20/2018	Sell	3,192	$125.41	$400,308.72	8,808
2/16/2018	Sell	8,808	$125.03	$1,101,264.24	8,808
2/14/2018	Sell	9,737	$120.05	$1,168,926.85	9,737
2/12/2018	Sell	27,630	$116.46	$3,217,789.80	11,718
2/9/2018	Sell	11,718	$115.87	$1,357,764.66	11,718
10/10/2017	Sell	15,000	$94.93	$1,423,950.00
8/10/2017	Sell	6,667	$92.64	$617,630.88	15,000
5/10/2017	Sell	6,666	$83.24	$554,877.84	25,758
4/6/2016	Sell	9,278	$46.18	$428,458.04	38,332
3/31/2016	Sell	4,360	$44.33	$193,278.80	48,332
10/1/2015	Sell	10,185	$47.94	$488,268.90	43,890
9/1/2015	Sell	6,500	$48.21	$313,365.00	49,075
2/23/2015	Sell	15,687	$33.10	$519,239.70
1/23/2015	Sell	15,687	$31.53	$494,611.11
12/23/2014	Sell	15,687	$29.85	$468,256.95
11/21/2014	Sell	15,687	$24.49	$384,174.63
10/23/2014	Sell	15,687	$20.50	$321,583.50
9/23/2014	Sell	15,687	$20.01	$313,896.87

Alison Bauerlein Buying and Selling Activity at Inogen

Inogen Company Overview

Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Simeox airway clearance; batteries; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.

Today's Range

Now: $10.05

$9.70

$10.08

50 Day Range

MA: $9.82

$8.69

$11.56

2 Week Range

Now: $10.05

$4.93

$13.33

Volume

171,150 shs

Average Volume

333,613 shs

Market Capitalization

$239.39 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.04

From Porter & Company | Ad

The AI boom is just getting started. And the real wealth has still to be made…

You must read this new presentation from Porter Stansberry.